An innovative nanoparticle vaccine candidate for the pandemic coronavirus produces virus-neutralizing antibodies in mice at levels 10 times greater than is seen in people who have recovered from COVID-19 infections. Designed by scientists at the University of Washington School of Medicine in Seattle, the vaccine candidate has been transferred to two companies for clinical
Watching
Latest
-
Wegman uses biometric surveillance on shoppers, raising privacy concerns
-
UK ordered agents to find UFO tech in bombshell 1990s secret files shocker | New York Post
-
Private equity barons target savers in hunt for ‘the perfect bailout’
-
Giant structure discovered deep beneath Bermuda is unlike anything else on Earth | Live Science
